Cancer Research
Learn more about translational cancer research at the Rudy L. Ruggles Biomedical Research Institute.
The Rudy L. Ruggles Biomedical Research Institute at Nuvance Health™ conducts translational cancer research to study disease prevention, early disease diagnosis and treatments.
Translational cancer research brings new disease prevention, early diagnosis and treatments to the bedside to improve patient outcomes. Cancer researchers at the Rudy L. Ruggles Biomedical Research Institute work closely with clinicians across Nuvance Health. We also partner with other institutions to perform cancer research that aims to benefit patients across the country and world.
Highlights of the program include:
About Biomedical Cancer Research
The Rudy L. Ruggles Biomedical Research Institute works closely with Nuvance Health specialists to identify research opportunities. We perform basic science to answer fundamental questions about how life works and to inform potential prevention, early diagnosis and treatment approaches. Clinical trials with human volunteers build on this knowledge to discover the safest, most effective treatments.
Discover More About Nuvance Health Research Initiatives: